USANA Health Sciences Net Profit Margin 2006-2020 | USNA

USANA Health Sciences net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
USANA Health Sciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-09-30 $1.10B $0.12B 10.68%
2020-06-30 $1.06B $0.11B 10.40%
2020-03-31 $1.06B $0.10B 9.76%
2019-12-31 $1.06B $0.10B 9.43%
2019-09-30 $1.09B $0.10B 9.27%
2019-06-30 $1.13B $0.11B 9.60%
2019-03-31 $1.17B $0.12B 10.34%
2018-12-31 $1.19B $0.13B 10.60%
2018-09-30 $1.16B $0.09B 7.57%
2018-06-30 $1.13B $0.08B 7.18%
2018-03-31 $1.08B $0.07B 6.46%
2017-12-31 $1.05B $0.06B 5.92%
2017-09-30 $1.03B $0.09B 8.76%
2017-06-30 $1.02B $0.10B 9.42%
2017-03-31 $1.02B $0.10B 9.70%
2016-12-31 $1.01B $0.10B 9.94%
2016-09-30 $0.99B $0.10B 10.34%
2016-06-30 $0.97B $0.10B 10.16%
2016-03-31 $0.94B $0.10B 10.33%
2015-12-31 $0.92B $0.10B 10.35%
2015-09-30 $0.91B $0.09B 10.08%
2015-06-30 $0.87B $0.09B 9.75%
2015-03-31 $0.83B $0.08B 9.55%
2014-12-31 $0.79B $0.08B 9.62%
2014-09-30 $0.75B $0.08B 10.03%
2014-06-30 $0.73B $0.07B 10.00%
2014-03-31 $0.73B $0.08B 10.67%
2013-12-31 $0.72B $0.08B 11.00%
2013-09-30 $0.70B $0.08B 10.98%
2013-06-30 $0.69B $0.08B 11.13%
2013-03-31 $0.66B $0.07B 10.54%
2012-12-31 $0.65B $0.07B 10.17%
2012-09-30 $0.63B $0.06B 9.74%
2012-06-30 $0.61B $0.06B 9.26%
2012-03-31 $0.59B $0.05B 8.94%
2011-12-31 $0.58B $0.05B 8.58%
2011-09-30 $0.58B $0.05B 8.52%
2011-06-30 $0.57B $0.05B 8.83%
2011-03-31 $0.54B $0.05B 8.66%
2010-12-31 $0.52B $0.05B 8.88%
2010-09-30 $0.50B $0.04B 8.85%
2010-06-30 $0.47B $0.04B 8.25%
2010-03-31 $0.46B $0.04B 8.06%
2009-12-31 $0.44B $0.03B 7.78%
2009-09-30 $0.43B $0.03B 6.50%
2009-06-30 $0.43B $0.03B 6.56%
2009-03-31 $0.42B $0.03B 6.84%
2008-12-31 $0.43B $0.03B 6.76%
2008-09-30 $0.43B $0.04B 8.43%
2008-06-30 $0.43B $0.04B 9.15%
2008-03-31 $0.43B $0.04B 9.41%
2007-12-31 $0.42B $0.05B 10.61%
2007-09-30 $0.41B $0.04B 10.73%
2007-06-30 $0.40B $0.04B 10.86%
2007-03-31 $0.38B $0.04B 11.11%
2006-12-31 $0.37B $0.04B 10.96%
2006-09-30 $0.34B $0.04B 11.63%
2006-06-30 $0.33B $0.04B 11.98%
2006-03-31 $0.33B $0.04B 12.27%
2005-12-31 $0.32B $0.04B 12.38%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.805B $1.061B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.681B 44.19
Takeda Pharmaceutical (TAK) Japan $52.525B 9.15
Astellas Pharma (ALPMY) Japan $26.270B 0.00
Eisai (ESALY) Japan $23.622B 19.96
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $20.091B 0.00
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.467B 50.28
Grifols, S.A (GRFS) Spain $12.727B 15.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.233B 35.74
Jazz Pharmaceuticals (JAZZ) Ireland $8.333B 13.78
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.439B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.613B 41.89
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $6.023B 0.00
United Therapeutics (UTHR) United States $5.453B 12.61
Evotec AG (EVTCY) Germany $4.517B 145.40
ChemoCentryx (CCXI) United States $4.051B 0.00
FibroGen (FGEN) United States $3.849B 0.00
Sage Therapeutics (SAGE) United States $3.717B 0.00
PTC Therapeutics (PTCT) United States $3.518B 0.00
Hypermarcas (HYPMY) Brazil $3.483B 12.81
Nektar Therapeutics (NKTR) United States $3.138B 0.00
Revolution Medicines (RVMD) United States $2.661B 0.00
Pacira BioSciences (PCRX) United States $2.371B 62.33
Taro Pharmaceutical Industries (TARO) Israel $2.295B 11.11
Xencor (XNCR) United States $2.260B 0.00
Corcept Therapeutics (CORT) United States $2.063B 18.99
Cronos Group (CRON) Canada $2.040B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.980B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.561B 14.89
Ironwood Pharmaceuticals (IRWD) United States $1.542B 10.71
Heron Therapeutics (HRTX) United States $1.499B 0.00
Endo (ENDP) Ireland $1.331B 1.97
Trillium Therapeutics (TRIL) Canada $1.277B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.244B 0.00
Zogenix (ZGNX) United States $1.180B 0.00
Karyopharm Therapeutics (KPTI) United States $1.158B 0.00
Translate Bio (TBIO) United States $1.042B 0.00
Indivior (INVVY) United States $1.030B 12.77
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
ImmunoGen (IMGN) United States $0.953B 0.00
Esperion Therapeutics (ESPR) United States $0.899B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.880B 548.13
Tilray (TLRY) Canada $0.856B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.668B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.648B 32.29
Radius Health (RDUS) United States $0.640B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.623B 0.00
VAXART, INC (VXRT) United States $0.617B 0.00
Flexion Therapeutics (FLXN) United States $0.601B 0.00
Siga Technologies (SIGA) United States $0.533B 56.83
Spectrum Pharmaceuticals (SPPI) United States $0.495B 0.00
Molecular Templates (MTEM) United States $0.483B 0.00
Aerie Pharmaceuticals (AERI) United States $0.461B 0.00
Ardelyx (ARDX) United States $0.460B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Akebia Therapeutics (AKBA) United States $0.456B 0.00
Organogenesis Holdings (ORGO) United States $0.444B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.416B 0.00
TherapeuticsMD (TXMD) United States $0.403B 0.00
Altimmune (ALT) United States $0.395B 0.00
DURECT (DRRX) United States $0.387B 0.00
Harpoon Therapeutics (HARP) United States $0.386B 0.00
Redhill Biopharma (RDHL) Israel $0.362B 0.00
Concert Pharmaceuticals (CNCE) United States $0.353B 0.00
Profound Medical (PROF) Canada $0.342B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.330B 8.18
Jounce Therapeutics (JNCE) United States $0.323B 15.31
Innate Pharma SA (IPHYF) France $0.323B 0.00
MEI Pharma (MEIP) United States $0.321B 0.00
Menlo Therapeutics (VYNE) United States $0.315B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.311B 0.00
Lannett Co Inc (LCI) United States $0.282B 6.55
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
CTI BioPharma (CTIC) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.257B 0.00
Aduro Biotech (KDNY) United States $0.250B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
IMV INC (IMV) Canada $0.227B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.220B 0.00
CASI Pharmaceuticals (CASI) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.214B 21.14
Nivalis Therapeutics (ALPN) United States $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Otonomy (OTIC) United States $0.183B 0.00
Aquestive Therapeutics (AQST) United States $0.177B 0.00
Heat Biologics (HTBX) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
OptiNose (OPTN) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.173B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
ProPhase Labs (PRPH) United States $0.104B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.077B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.074B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.071B 0.00
Novan (NOVN) United States $0.070B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Biomerica (BMRA) United States $0.066B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.051B 0.00
Recro Pharma (REPH) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.32
Forward Pharma (FWP) Denmark $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
GTx (ONCT) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.032B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.020B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.017B 25.64
Vical (BBI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.011B 0.00
JanOne (JAN) United States $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00